In the current study, some phenolic compounds, including acteoside, isoacteoside, echinacoside, and arenarioside purified and characterized from Plantago subulata. These compounds were tested for its antioxidant potential, including Fe3+ and Cu2+ reductive ability and Fe2+ chelating effects. The inhibitory effects of isolated phenolic compounds were tested towards human carbonic anhydrase I and II isoenzymes (hCA I and hCA II), butyrylcholinesterase (BChE) acetylcholinesterase (AChE), aldose reductase (AR) and α‐glycosidase (α‐gly). Ki values were found these compounds in range of 0.24±0.05–1.38±0.34 μM against hCA I, 0.194±0.018–1.03±0.06 μM against hCA II, 0.043±0.01–0.154±0.02 μM against AChE, 3.92±1.08–11.93±4.45 μM against BChE, 0.082±0.0008–1.68±0.42 μM against AR, and 6.93±2.74–17.17±6.70 μM against α‐glycosidase. As a result, isolated compounds displayed inhibition effects against studied all metabolic enzymes. They are promising candidates for treating disorders like Alzheimer's disease, diabetes mellitus, glaucoma, leukemia, and epilepsy.